
Victoria Tuesday, October 2, 2018 11:30 AM Babies living with spinal muscular atrophy (SMA), a rare, severe and degenerative neuromuscular disease, soon will have access to Spinraza, a life-changing treatment. In line with the recommendation made by the independent Common Drug Review (CDR), starting in November, British Columbia will provide coverage for Spinraza for infants […]







